Detection of dihydrotestosterone gel, oral dehydroepiandrosterone, and testosterone gel misuse through the quantification of testosterone metabolites released after alkaline treatment

Drug Testing and Analysis

Volumn 3, Issue 11-12, 2011, Pages 828-835

  Fabregat, Andreu ^a   Pozo, Oscar J ^a   Van Renterghem, Pieter ^c   Van Eenoo, Peter ^c   Marcos, Josep ^a,b   Segura, Jordi ^a,b   Ventura, Rosa ^a,b  

^a HOSPITAL DEL MAR   (Spain)

^b UNIVERSITAT POMPEU FABRA   (Spain)

^c GHENT UNIVERSITY   (Belgium)

Author keywords

DHEA; DHT; Doping analysis; Mass spectrometry; Testosterone gel

Indexed keywords

BIOMOLECULES; LIPIDS; METABOLITES;

ALKALINE TREATMENT; ANABOLIC STEROID; DEHYDROEPIANDROSTERONE; DIHYDROTESTOSTERONE; DIHYDROTESTOSTERONE GEL; DOPING ANALYSIS; DOPING CONTROL; ENDOGENOUS STEROIDS; TESTOSTERONE; TESTOSTERONE GEL;

MASS SPECTROMETRY;

17BETA HYDROXY ANDROST 4,6 DIEN 3 ONE; ANDROST 1,4 DIEN 3,17 DIONE; ANDROST 15 EN 3,17 DIONE; ANDROST 4,6 DIEN 3,17 DIONE; ANDROSTANOLONE; DRUG METABOLITE; PRASTERONE; TESTOSTERONE; UNCLASSIFIED DRUG;

ARTICLE; DRUG DETERMINATION; DRUG MISUSE; DRUG URINE LEVEL; HUMAN; LIQUID CHROMATOGRAPHY; MASS FRAGMENTOGRAPHY; MASS SPECTROMETRY; NORMAL HUMAN; PRIORITY JOURNAL; URINALYSIS;

EID: 84855234761     PISSN: 19427603     EISSN: 19427611     Source Type: Journal    
DOI: 10.1002/dta.351     Document Type: Article

References (30)

1. C. Saudan, N. Baume, N. Robinson, L. Avois, P. Mangin, M. Saugy Br. J. Sports Med. 2006, 40, i21.
2. WADA (World Anti-doping Agency). Prohibited list 2010. Available at: [August 2011].
3. A. Aguilera, M. Becchi, H. Casabianca, C. K. Hatton, D. H. Catlin, B. Starcevic, H. G. Pope J. Mass Spectrom. 1996, 31, 169.
4. A. T. Cawley, U. Flenker J. Mass Spectrom. 2008, 43, 854.
5. M. Donike, K. R. Barwald, K. Klostermann, W. Schänzer, J. Zimmermann Nachweis von exogenem testosterone, in Sport: Leistung und Fesundhei, (Eds: H. Heck, H. Hollmann, H. Liesen, R. Rost ). SPORT and BUCH Strauβ: Köln Cologne, 1983, pp. 293-298.
6. WADA (World Anti-doping Agency). Technical document-TD2004EAAS 2004. Available at: [August 2011].
7. J. Jakobsson, L. Ekstrom, N. Inotsume, M. Garle, M. Lorentzon, C. Ohlsson, H. K. Roh, K. Calstrom, A. Rane J. Clin. Endocrinol. Metab. 2006, 91, 687.
8. T. Sten, I. Bichlmaier, T. Kuuranne, A. Leinonen, J. Yli-Kauhaluoma, M. Finel Drug Metab. 2009, 37, 417.
9. M. Donike, U. Engelke, S. Rauth Statistical evaluation of longitudinal studies, part 2: the usefulness of subjected based reference ranges, in Proceedings of the 11th Cologne Workshop on Dope Analysis, (Eds: M. Donike, H. Geyer, A. Gotzmann, U. Mareck-Engelke, S. Ruth ). SPORT and BUCH Strauβ: Köln Cologne, 1995, pp. 121-133.
10. P. E. Sottas, N. Baume, C. Schweizer, P. Mangin, M. Saugy Forensic Sci. Int. 2008, 8, 285.
11. J. J. Schulze, J. Lundmark, M. Garle, I. Skilving, L. Ekström, A. Rane J. Clin. Endocrinol. Metab. 2008, 93, 2500.
12. WADA (World Anti-doping Agency). Statistics 2010. Available at: [August 2011].
13. H. Geyer, U. Flenker, U. Mareck, F. Sommer, W. Shänzer Preliminary results regarding the detection of the misuse of testosterone gel, in Proceedings of the 12th Cologne Workshop on Dope Analysis, (Eds: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck ). SPORT and BUCH Strauβ: Köln Cologne, 2004, pp.121-129.
14. P. Van Renterghem, P. Van Eenoo, F. T. Delbeke Steroids 2010, 75, 1047.
15. H. Geyer, U. Flenker, U. Mareck, P. Platen, T. Piper, A. Schechel, Y. Schrader, M. Thevis, W. Shänzer The detection of the misuse of testosterone gel, in Proceedings of the 15th Cologne Workshop on Dope Analysis, (Eds: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck ). SPORT and BUCH Strauβ: Köln Cologne, 2007, pp. 123-142.
16. A. T. Cawley, E. R. Hine, G. J. Trout, A. V. George, R. Kazlauskas Forensic Sci. Int. 2004, 143, 103.
17. T. Z. Bosy, K. A. Moore, A. Poklis J. Anal. Toxicol. 1998, 22, 445.
18. L. Dehennin, M. Ferry, P. Lafarge, G. Pérès, J. P. Lafarge Steroids 1998, 63, 80.
19. J. F. Lévesque, C. Ayotte The oral administration of DHEA: the efficiency of steroid profiling, in Proceedings of the 7th Cologne Workshop on Dope Analysis, (Eds: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck ). SPORT and BUCH Strauβ: Köln Cologne, 1999, pp. 213-221.
20. P. Van Renterghem, P. Van Eenoo, P. E. Sottas, M. Saugy, F. T. Delbeke Drug Test. Analysis 2010, 2, 582.
21. V. A. Randall J. Clin. Endocrinol. Metab. 1994, 8(2), 405.
22. A. T. Kickman, S. B. Coutts, C. J. Walker, D. A. Cowan Clin. Chem. 1995, 41, 1617.
23. M. Donike, M. Ueki, Y. Kuroda, H. Geyer, E. Nolteernsting, S. Rauth, W. Shänzer, U. Shindler, E. Völker, M. Fujisaki J. Sports Med. Phys. Fitness 1995, 35, 235.
24. O. J. Pozo, J. Marcos, R. Ventura, A. Fabregat, J. Segura Anal. Bioanal. Chem. 2010, 398, 1759.
25. A. Fabregat, O. J. Pozo, J. Marcos, J. Segura, R. Ventura Drug Test. Analysis 2010, 2, 630.
26. A. Fabregat, O. J. Pozo, J. Marcos, R. Ventura, J. Segura Steroids 2011, 76(12), 1367.
27. P. Van Renterghem, P. Van Eenoo, W. Van Thuyne, H. Geyer, W. Schänzer, F. T. Delbeke J. Chromatogr. B 2008, 876, 225.
28. P. Van Renterghem, P. Van Eenoo, H. Geyer, W. Schänzer, F. T. Delbeke Steroids 2010, 75, 154.
29. U. Mareck, H. Geyer, G. Fuβhöller, A. Schwenke, N. Haenelt, T. Piper, M. Thevis, W. Schänzer Drug Test. Analysis 2010, 2, 637.
30. M. Thevis, T. Kuuranne, H. Geyer, W. Schänzer Drug Test. Analysis 2011, 3, 1.